Copyright Reports & Markets. All rights reserved.

Global Lewy Body Dementia Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Lewy Body Dementia Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Modafinil
      • 1.4.3 Benzodiazepine
      • 1.4.4 Antidepressants
      • 1.4.5 Cholinesterase Inhibitors
      • 1.4.6 Antipsychotic Drugs
      • 1.4.7 Carbidopa-Levodopa
    • 1.5 Market by Application
      • 1.5.1 Global Lewy Body Dementia Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Lewy Body Dementia Treatment Market Size
    • 2.2 Lewy Body Dementia Treatment Growth Trends by Regions
      • 2.2.1 Lewy Body Dementia Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Lewy Body Dementia Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Lewy Body Dementia Treatment Market Size by Manufacturers
      • 3.1.1 Global Lewy Body Dementia Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Lewy Body Dementia Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Lewy Body Dementia Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Lewy Body Dementia Treatment Key Players Head office and Area Served
    • 3.3 Key Players Lewy Body Dementia Treatment Product/Solution/Service
    • 3.4 Date of Enter into Lewy Body Dementia Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Lewy Body Dementia Treatment Market Size by Type (2014-2019)
    • 4.2 Global Lewy Body Dementia Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Lewy Body Dementia Treatment Market Size (2014-2019)
    • 5.2 Lewy Body Dementia Treatment Key Players in United States
    • 5.3 United States Lewy Body Dementia Treatment Market Size by Type
    • 5.4 United States Lewy Body Dementia Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Lewy Body Dementia Treatment Market Size (2014-2019)
    • 6.2 Lewy Body Dementia Treatment Key Players in Europe
    • 6.3 Europe Lewy Body Dementia Treatment Market Size by Type
    • 6.4 Europe Lewy Body Dementia Treatment Market Size by Application

    7 China

    • 7.1 China Lewy Body Dementia Treatment Market Size (2014-2019)
    • 7.2 Lewy Body Dementia Treatment Key Players in China
    • 7.3 China Lewy Body Dementia Treatment Market Size by Type
    • 7.4 China Lewy Body Dementia Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Lewy Body Dementia Treatment Market Size (2014-2019)
    • 8.2 Lewy Body Dementia Treatment Key Players in Japan
    • 8.3 Japan Lewy Body Dementia Treatment Market Size by Type
    • 8.4 Japan Lewy Body Dementia Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Lewy Body Dementia Treatment Market Size (2014-2019)
    • 9.2 Lewy Body Dementia Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Lewy Body Dementia Treatment Market Size by Type
    • 9.4 Southeast Asia Lewy Body Dementia Treatment Market Size by Application

    10 India

    • 10.1 India Lewy Body Dementia Treatment Market Size (2014-2019)
    • 10.2 Lewy Body Dementia Treatment Key Players in India
    • 10.3 India Lewy Body Dementia Treatment Market Size by Type
    • 10.4 India Lewy Body Dementia Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Lewy Body Dementia Treatment Market Size (2014-2019)
    • 11.2 Lewy Body Dementia Treatment Key Players in Central & South America
    • 11.3 Central & South America Lewy Body Dementia Treatment Market Size by Type
    • 11.4 Central & South America Lewy Body Dementia Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Lewy Body Dementia Treatment Introduction
      • 12.1.4 Novartis Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.1.5 Novartis Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Lewy Body Dementia Treatment Introduction
      • 12.2.4 Pfizer Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Bayer
      • 12.3.1 Bayer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Lewy Body Dementia Treatment Introduction
      • 12.3.4 Bayer Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.3.5 Bayer Recent Development
    • 12.4 GlaxoSmithKline
      • 12.4.1 GlaxoSmithKline Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Lewy Body Dementia Treatment Introduction
      • 12.4.4 GlaxoSmithKline Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.4.5 GlaxoSmithKline Recent Development
    • 12.5 Mylan
      • 12.5.1 Mylan Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Lewy Body Dementia Treatment Introduction
      • 12.5.4 Mylan Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.5.5 Mylan Recent Development
    • 12.6 Sanofi
      • 12.6.1 Sanofi Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Lewy Body Dementia Treatment Introduction
      • 12.6.4 Sanofi Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.6.5 Sanofi Recent Development
    • 12.7 Johnson & Johnson
      • 12.7.1 Johnson & Johnson Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Lewy Body Dementia Treatment Introduction
      • 12.7.4 Johnson & Johnson Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.7.5 Johnson & Johnson Recent Development
    • 12.8 Teva Pharmaceuticals
      • 12.8.1 Teva Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Lewy Body Dementia Treatment Introduction
      • 12.8.4 Teva Pharmaceuticals Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.8.5 Teva Pharmaceuticals Recent Development
    • 12.9 Eli Lilly
      • 12.9.1 Eli Lilly Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Lewy Body Dementia Treatment Introduction
      • 12.9.4 Eli Lilly Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.9.5 Eli Lilly Recent Development
    • 12.10 Eisai
      • 12.10.1 Eisai Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Lewy Body Dementia Treatment Introduction
      • 12.10.4 Eisai Revenue in Lewy Body Dementia Treatment Business (2014-2019)
      • 12.10.5 Eisai Recent Development
    • 12.11 Takeda Pharmaceutical
    • 12.12 Allergan
    • 12.13 Bausch Health Companies
    • 12.14 BioArctic
    • 12.15 Sumitomo Dainippon Pharma
    • 12.16 Jazz Pharmaceuticals
    • 12.17 Hisamitsu Pharmaceutical

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Lewy body dementia (LBD, sometimes referred to as Lewy body disorder) is an umbrella term that includes Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), two dementias characterized by abnormal deposits of the protein alpha-synuclein in the brain.
      In 2018, the global Lewy Body Dementia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Lewy Body Dementia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lewy Body Dementia Treatment development in United States, Europe and China.

      The key players covered in this study
      Novartis
      Pfizer
      Bayer
      GlaxoSmithKline
      Mylan
      Sanofi
      Johnson & Johnson
      Teva Pharmaceuticals
      Eli Lilly
      Eisai
      Takeda Pharmaceutical
      Allergan
      Bausch Health Companies
      BioArctic
      Sumitomo Dainippon Pharma
      Jazz Pharmaceuticals
      Hisamitsu Pharmaceutical

      Market segment by Type, the product can be split into
      Modafinil
      Benzodiazepine
      Antidepressants
      Cholinesterase Inhibitors
      Antipsychotic Drugs
      Carbidopa-Levodopa

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Lewy Body Dementia Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Lewy Body Dementia Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Lewy Body Dementia Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now